Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hernández-Blasco LM"'
Autor:
Mahé I, Sterpu R, Bertoletti L, López-Jiménez L, Mellado Joan M, Trujillo-Santos J, Ballaz A, Hernández Blasco LM, PABLO MARCHENA YGLESIAS, Monreal M, RIETE Investigators
Publikováno v:
PLoS One
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Current guidelines of antithrombotic therapy suggest early initiation of vitamin K antagonists (VKA) in non-cancer patients with venous thromboembolism (VTE), and long-term therapy with low-molecular weight heparin (LMWH) for those with cancer. We us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::02c3b46cd2fb65ed7ab22ebebd30e939
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12620
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12620
Autor:
Gonzaga A; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; Institute of Bioengineering, Miguel Hernández University, Elche, Spain., Andreu E; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; Applied Physics Department, Miguel Hernández University, Elche, Spain., Hernández-Blasco LM; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Meseguer R; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; Clinic University Hospital, Fundación para la Investigación del Hospital Clínico de la Comunidad Valenciana (INCLIVA) Health Research Institute, Valencia, Spain., Al-Akioui-Sanz K; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain., Soria-Juan B; Réseau Hospitalier Neuchâtelois, Hôpital Pourtalès, Neuchâtel, Switzerland., Sanjuan-Gimenez JC; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Ferreras C; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain., Tejedo JR; Department of Molecular Biology and Biochemical Engineering, University Pablo de Olavide, Seville, Spain.; Biomedical Research Network for Diabetes and Related Metabolic Diseases-Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) of the Carlos III Health Institute (ISCIII), Madrid, Spain., Lopez-Lluch G; University Pablo de Olavide, Centro Andaluz de Biología del Desarrollo - Consejo Superior de Investigaciones Científicas (CABD-CSIC), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Sevilla, Spain., Goterris R; Clinic University Hospital, Fundación para la Investigación del Hospital Clínico de la Comunidad Valenciana (INCLIVA) Health Research Institute, Valencia, Spain., Maciá L; Nursing Department, University of Alicante, Alicante, Spain., Sempere-Ortells JM; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; Biotechnology Department, University of Alicante, Alicante, Spain., Hmadcha A; Department of Molecular Biology and Biochemical Engineering, University Pablo de Olavide, Seville, Spain.; Biosanitary Research Institute (IIB-VIU), Valencian International University (VIU), Valencia, Spain., Borobia A; Clinical Pharmacology Department, La Paz University Hospital, School of Medicine, Universidad Autónoma de Madrid, IdiPAz, Madrid, Spain., Vicario JL; Transfusion Center of the Autonomous Community of Madrid, Madrid, Spain., Bonora A; Health Research Institute Hospital La Fe, Valencia, Spain., Aguilar-Gallardo C; Health Research Institute Hospital La Fe, Valencia, Spain., Poveda JL; Health Research Institute Hospital La Fe, Valencia, Spain., Arbona C; Valencian Community Blood Transfusion Center, Valencia, Spain., Alenda C; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Tarín F; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Marco FM; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; Immunology Department, Dr. Balmis General University Hospital, Alicante, Spain., Merino E; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; Department of Clinical Medicine, Miguel Hernández University, Elche, Spain.; Infectious Diseases Unit, Dr. Balmis General University Hospital, Alicante, Spain., Jaime F; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Ferreres J; Intensive Care Service, Hospital Clinico Universitario, Fundación para la Investigación del Hospital Clínico de la Comunidad Valenciana (INCLIVA), Valencia, Spain., Figueira JC; Intensive Care Unit, Hospital Universitario La Paz - IdiPAZ, Madrid, Spain., Cañada-Illana C; Emergency Department, Hospital Universitario La Paz - IdiPAZ, Madrid, Spain., Querol S; Banc de Sang I Teixits, Barcelona, Spain., Guerreiro M; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Eguizabal C; Research Unit, Basque Center for Blood Transfusion and Human Tissues, Galdakao, Spain.; Cell Therapy, Stem Cells and Tissues Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain., Martín-Quirós A; Emergency Department, Hospital Universitario La Paz - IdiPAZ, Madrid, Spain., Robles-Marhuenda Á; Internal Medicine Department, Hospital Universitario La Paz - IdiPAZ, Madrid, Spain., Pérez-Martínez A; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain.; Department of Pediatrics, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., Solano C; Hematology Service, Hospital Clínico Universitario, Fundación para la Investigación del Hospital Clínico de la Comunidad Valenciana (INCLIVA), Valencia, Spain., Soria B; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; Institute of Bioengineering, Miguel Hernández University, Elche, Spain.; Biomedical Research Network for Diabetes and Related Metabolic Diseases-Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) of the Carlos III Health Institute (ISCIII), Madrid, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Sep 11; Vol. 14, pp. 1232472. Date of Electronic Publication: 2023 Sep 11 (Print Publication: 2023).
Autor:
Lecumberri R; Hematology Service, Clínica Universidad de Navarra, Pamplona, Spain.; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain., Ruiz-Artacho P; Department of Internal Medicine, Clínica Universidad de Navarra, Madrid, Spain.; CIBERES, Instituto de Salud Carlos III, Madrid, Spain., Tzoran I; Hematology Service, Rambam - Health Care Campus, Haifa, Israel., Brenner B; Hematology Service, Rambam - Health Care Campus, Haifa, Israel., Farge-Bancel D; Internal Medicine Unit UF (04), Hôpital Saint-Louis, AP-HP, Université de Paris, Paris, France., Ay C; Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Rosa V; Department of Internal Medicine, Hospital Universitario Virgen de Arrixaca, Murcia, Spain., Francisco I; Department of Internal Medicine, Hospital Universitari de Girona Dr. Josep Trueta, Gerona, Spain., Hernández-Blasco LM; Department of Pneumonology, Hospital General Universitario de Alicante, ISABIAL, UMH, Alicante, Spain., Trujillo-Santos J; Department of Internal Medicine, Hospital General Universitario Santa Lucía, Universidad Católica de Murcia, Murcia, Spain., Monreal M; Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.; Department of Thromboembolic Disease, Faculty of Health Sciences, UCAM - Universidad Católica San Antonio de Murcia, CIBERES, Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2022 Sep; Vol. 122 (9), pp. 1594-1602. Date of Electronic Publication: 2022 Feb 21.
Autor:
Sánchez-Guijo F; Cell Therapy Area, Hematology Department, IBSAL-Hospital Universitario de Salamanca, Universidad de Salamanca, Salamanca, Spain.; RETIC TerCel, ISCIII, Madrid, Spain.; Grupo Español de Trasplante y Terapia Celular (GETH), Spain., García-Arranz M; RETIC TerCel, ISCIII, Madrid, Spain.; New Therapies Unit, Health Research Institute Fundación Jiménez Díaz, Madrid, Spain.; Surgery Department. School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., López-Parra M; Cell Therapy Area, Hematology Department, IBSAL-Hospital Universitario de Salamanca, Universidad de Salamanca, Salamanca, Spain.; RETIC TerCel, ISCIII, Madrid, Spain.; Grupo Español de Trasplante y Terapia Celular (GETH), Spain., Monedero P; Department of Anesthesia and Intensive Care, Clínica Universidad de Navarra, Pamplona, Spain., Mata-Martínez C; Instituto de Investigación Sanitaria (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain., Santos A; Intensive Care Unit, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; CIBER de Enfermedades Respiratorias CIBERES, Madrid, Spain., Sagredo V; Intensive Care Unit, IBSAL- Hospital Universitario de Salamanca, University of Salamanca, Salamanca, Spain., Álvarez-Avello JM; Department of Anesthesia and Intensive Care, Clínica Universidad de Navarra, Pamplona, Spain., Guerrero JE; Instituto de Investigación Sanitaria (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain., Pérez-Calvo C; Intensive Care Unit, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Sánchez-Hernández MV; Department of Anesthesia, IBSAL- Hospital Universitario de Salamanca, University of Salamanca, Salamanca, Spain., Del-Pozo JL; Infectious Diseases Division, Microbiology Department, Clínica Universidad de Navarra, Spain., Andreu EJ; RETIC TerCel, ISCIII, Madrid, Spain.; Cell Therapy Area and Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain., Fernández-Santos ME; RETIC TerCel, ISCIII, Madrid, Spain.; Instituto de Investigación Sanitaria (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain.; CIBER Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., Soria-Juan B; New Therapies Unit, Health Research Institute Fundación Jiménez Díaz, Madrid, Spain., Hernández-Blasco LM; Hospital General Universitario de Alicante (Universidad Miguel Hernandez-ISABIAL), Alicante, Spain., Andreu E; Hospital General Universitario de Alicante (Universidad Miguel Hernandez-ISABIAL), Alicante, Spain., Sempere JM; Hospital General Universitario de Alicante (Departamento de Biotecnología, Universidad de Alicante-ISABIAL), Alicante, Spain., Zapata AG; RETIC TerCel, ISCIII, Madrid, Spain.; Department of Cell Biology, Universidad Complutense, Madrid, Spain., Moraleda JM; RETIC TerCel, ISCIII, Madrid, Spain.; Grupo Español de Trasplante y Terapia Celular (GETH), Spain.; Servicio de Hematología, Hospital Clinico Universitario Virgen de la Arrixaca, IMIB, Universidad de Murcia, Murcia, Spain., Soria B; Hospital General Universitario de Alicante (Universidad Miguel Hernandez-ISABIAL), Alicante, Spain.; Institute of Bioengineering, Universidad Miguel Hernández, Alicante, Spain., Fernández-Avilés F; RETIC TerCel, ISCIII, Madrid, Spain.; Instituto de Investigación Sanitaria (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain.; CIBER Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.; Department of Medicine, Universidad Complutense, Madrid, Spain., García-Olmo D; RETIC TerCel, ISCIII, Madrid, Spain.; New Therapies Unit, Health Research Institute Fundación Jiménez Díaz, Madrid, Spain.; Surgery Department. School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.; Department of Surgery, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Prósper F; RETIC TerCel, ISCIII, Madrid, Spain.; Grupo Español de Trasplante y Terapia Celular (GETH), Spain.; Cell Therapy Area and Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain.
Publikováno v:
EClinicalMedicine [EClinicalMedicine] 2020 Aug; Vol. 25, pp. 100454. Date of Electronic Publication: 2020 Jul 10.
Autor:
Cote LP; 1 Department of Nursing/Critical Care, Evanston Hospital, NorthShore University HealthSystem, Evanston, IL, USA., Greenberg S; 2 Department of Anesthesia/Critical Care, Evanston Hospital, NorthShore University HealthSystem, Chicago, IL, USA., Caprini JA; 3 Division of Vascular Surgery, Evanston Hospital, NorthShore University HealthSystem, Chicago, IL, USA., Tafur A; 3 Division of Vascular Surgery, Evanston Hospital, NorthShore University HealthSystem, Chicago, IL, USA., Choi C; 4 Department of Anesthesiology, Yale-New Haven Hospital, New Haven, CT, USA., Muñoz FJ; 5 Department of Internal Medicine, Fundació Privada Hospital de Mollet, Barcelona, Spain., Skride A; 6 Department of Cardiology, Ospedale Pauls Stradins Clinical University Hospital, Riga, Latvia., Valero B; 7 Department of Internal Medicine, Hospital General Universitario de Alicante, Alicante, Spain., Porras JA; 8 Department of Internal Medicine, Hospital Universitario Joan XXIII de Tarragona, Tarragona, Spain., Ciammaichella M; 9 Department of Emergency Internal Medicine, Ospedale St John, Rome, Italy., Hernández-Blasco LM; 10 Department of Pneumonology, Hospital General Universitario de Alicante, Alicante, Spain., Monreal M; 11 Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2017 Oct; Vol. 23 (7), pp. 748-754. Date of Electronic Publication: 2016 Aug 29.